Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2191]
News [5896]
Articles [117]
Editorials [31]
Conferences [186]
elearning [22]
First evidence of significant clinical activity of PD1 inhibition in metastatic...
Dr Julie Graff - Knight Cancer Institute, Oregon Health & Science University...
First evidence of significant clinical activity of PD1 inhibition in metastatic prostate cancer ( Dr Julie Graff - Knight Cancer Institute, Oregon Health & Science University, Portland, USA )
17 Oct 2016
CDK4/6 inhibitors for metastatic breast cancer
Dr Giuseppe Curigliano - European Institute of Oncology, Milan, Italy
CDK4/6 inhibitors for metastatic breast cancer ( Dr Giuseppe Curigliano - European Institute of Oncology, Milan, Italy )
14 Oct 2016
TRAIL induced apoptosis for cancer stem cells
Prof Waleed Arafat - Alexandria Faculty of Medicine, Alexandria, Egypt
TRAIL induced apoptosis for cancer stem cells ( Prof Waleed Arafat - Alexandria Faculty of Medicine, Alexandria, Egypt )
12 Oct 2016
Drug repurposing of propranolol
Dr Pan Pantziarka - Anticancer Fund, UK
Drug repurposing of propranolol ( Dr Pan Pantziarka - Anticancer Fund, UK )
12 Oct 2016
ESMO 2016 conference highlights
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ESMO 2016 conference highlights ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
12 Oct 2016
Risk of serious and fatal adverse events with sorafenib use in patients with...
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
Risk of serious and fatal adverse events with sorafenib use in patients with solid cancers ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
12 Oct 2016
Combination of MEDI0680, an anti-PD-1 antibody, with durvalumab, an anti-PD-L1...
Dr Omid Hamid - The Angeles Clinic, California, USA
Combination of MEDI0680, an anti-PD-1 antibody, with durvalumab, an anti-PD-L1 antibody: ( Dr Omid Hamid - The Angeles Clinic, California, USA )
12 Oct 2016
Results of the Activ8 trial of novel immunotherapy motolimod
Dr Ezra Cohen - UC San Diego, San Diego, USA
Results of the Activ8 trial of novel immunotherapy motolimod ( Dr Ezra Cohen - UC San Diego, San Diego, USA )
10 Oct 2016
Lurbinectedin in PARP resistant breast cancer
Dr Cristina Cruz - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Lurbinectedin in PARP resistant breast cancer ( Dr Cristina Cruz - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
10 Oct 2016
Lurbinectedin in BRCA 1/2 breast cancer
Dr Judith Balmaña - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Lurbinectedin in BRCA 1/2 breast cancer ( Dr Judith Balmaña - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
10 Oct 2016
Innovative uses of kinase inhibitors in cancer
Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Innovative uses of kinase inhibitors in cancer ( Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
10 Oct 2016
Comment: Ribociclib for breast cancer
Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium
Comment: Ribociclib for breast cancer ( Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium )
10 Oct 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation